Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POINT X: Xiapex in Dupuytren's Contracture
NCT01229436Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Oct 2012
- Modality
- Therapeutic Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on NCT01229436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229436.